{"version":"1.0","type":"rich","provider_name":"techandbusiness.org","provider_url":"https://techandbusiness.org","title":"FDA Issues First Comprehensive Guidance for Psychedelic Drug Clinical Trials","author_name":"techandbusiness.org · Policy","thumbnail_url":"https://assets.newatlas.com/dims4/default/9660ab1/2147483647/strip/true/crop/5184x2722+0+367/resize/1200x630!/quality/90/?url=https%3A%2F%2Fnewatlas-brightspot.s3.ap-southeast-2.amazonaws.com%2Fb2%2F73%2Fe56c79444642bf723c46fec27552%2Fdepositphotos-304421504-xl.jpg&rf.image_optimisation=0","width":600,"height":400,"html":"<blockquote class=\"tb-newswire-embed\" style=\"max-width:600px;border-left:3px solid #22d3ee;padding:12px 16px;margin:0;font-family:-apple-system,system-ui,sans-serif;background:#09090b;border-radius:0 8px 8px 0;\">\n      <p style=\"margin:0 0 8px;font-size:10px;font-weight:600;letter-spacing:0.1em;color:#71717a;\">techandbusiness.org · Policy</p>\n      <p style=\"margin:0 0 8px;font-size:18px;font-weight:700;line-height:1.3;color:#fff;\"><a href=\"https://techandbusiness.org/newswire/L1yiq2ziW08UMiWrfzmAr9\" style=\"color:#fff;text-decoration:none;\">FDA Issues First Comprehensive Guidance for Psychedelic Drug Clinical Trials</a></p>\n      <p style=\"margin:0;font-size:14px;color:#a1a1aa;line-height:1.5;\">The U.S. Food and Drug Administration has issued its first comprehensive guidance on how psychedelic drugs should be studied in clinical trials, signaling a shift toward recognizing the therapeutic po...</p>\n    </blockquote>"}